42 results on '"Bethel, Paul A."'
Search Results
2. Development of Commercial Manufacturing Processes for Acalabrutinib
3. Optimized scale up of 3-pyrimidinylpyrazolo[1,5-a]pyridine via Suzuki coupling; a general method of accessing a range of 3-(hetero)arylpyrazolo[1,5-a]pyridines
4. Discovery of a Potent and Selective Oral Inhibitor of ERK1/2 (AZD0364) That Is Efficacious in Both Monotherapy and Combination Therapy in Models of Nonsmall Cell Lung Cancer (NSCLC)
5. Thermal Stability of 2-Butynoic Acid (Tetrolic Acid)
6. Synthesis of a Protected keto-Lysidine Analogue via Improved Preparation of Arabino-isoCytosine Nucleosides
7. Your letters.
8. Structure-Guided Discovery of Potent and Selective Inhibitors of ERK1/2 from a Modestly Active and Promiscuous Chemical Start Point
9. Preparation of differentially substituted 3,6-diaminopyridazines under mild conditions
10. The discovery of N-cyclopropyl-4-methyl-3-[6-(4-methylpiperazin-1-yl)-4-oxoquinazolin-3(4H)-yl]benzamide (AZD6703), a clinical p38α MAP kinase inhibitor for the treatment of inflammatory diseases
11. ChemInform Abstract: Preparation of Differentially Substituted 3,6-Diaminopyridazines under Mild Conditions.
12. Discovery of a Potent and Selective EGFR Inhibitor (AZD9291) of Both Sensitizing and T790M Resistance Mutations That Spares the Wild Type Form of the Receptor
13. ChemInform Abstract: Novel and Versatile Synthesis of Disubstituted 1,2‐Dihydro‐1,2,4‐triazol‐3‐ones.
14. ChemInform Abstract: Catalytic Synthesis of Riboside—Amino Acid Hybrids.
15. Dipeptidyl nitrile inhibitors of Cathepsin L
16. Design of selective Cathepsin inhibitors
17. Novel and Versatile Synthesis of Disubstituted 1,2-Dihydro-1,2,4-triazol-3-ones
18. Structure- and Reactivity-Based Development of Covalent Inhibitors of the Activating and Gatekeeper Mutant Forms of the Epidermal Growth Factor Receptor (EGFR)
19. Catalytic Synthesis of Riboside-Amino Acid Hybrids
20. ChemInform Abstract: Optimized Scale up of 3-Pyrimidinylpyrazolo[1,5-a]pyridine via Suzuki Coupling; a General Method of Accessing a Range of 3-(Hetero)arylpyrazolo[1,5-a]pyridines.
21. ChemInform Abstract: A Formal Synthesis of (+)-Pyripyropene A Using a Biomimetic Epoxy-Olefin Cyclization: Effect of Epoxy Alcohol/Ether on Cyclization Efficiency.
22. ChemInform Abstract: Reactions of Organotin Tetrazoles: Synthesis of Functionalized Poly‐tetrazoles.
23. Discovery of a Potent andSelective EGFR Inhibitor (AZD9291) of Both Sensitizing and T790M ResistanceMutations That Spares the Wild Type Form of the Receptor.
24. ChemInform Abstract: A Formal Synthesis of (+)‐Pyripyropene A Using a Biomimetic Epoxy‐Olefin Cyclization.
25. A formal synthesis of (+)-pyripyropene A using a biomimetic epoxy-olefin cyclisation: effect of epoxy alcohol/ether on cyclisation efficiency
26. A formal synthesis of (+)-pyripyropene A using a biomimetic epoxy-olefin cyclisation
27. Reactions of organotin tetrazoles: synthesis of functionalised poly-tetrazoles
28. Structure-and Reactivity-Based Development of CovalentInhibitors of the Activating and Gatekeeper Mutant Forms of the EpidermalGrowth Factor Receptor (EGFR).
29. Well-timed advice. (Letter of the month)
30. LETTERS.
31. LETTERS.
32. Catalytic Synthesis of Riboside—Amino Acid Hybrids.
33. THE REVOLUTION IN THE THIRD WORLD.
34. Can Castro Start a New Vietnam ?
35. Dominican Intervention: The Myths.
36. BLACK POWER AND RED CUBA.
37. A formal synthesis of (+)-pyripyropene A using a biomimetic epoxy-olefin cyclisation
38. ChemInform Abstract: A Formal Synthesis of (+)-Pyripyropene A Using a Biomimetic Epoxy-Olefin Cyclization: Effect of Epoxy Alcohol/Ether on Cyclization Efficiency.
39. Reactions of organotin tetrazoles: synthesis of functionalised poly-tetrazoles.
40. A formal synthesis of (+)-pyripyropene A using a biomimetic epoxy-olefin cyclisation: effect of epoxy alcohol/ether on cyclisation efficiency.
41. Letters.
42. Word origins and meanings.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.